Comparison

Recombinant Human TACI (ED)

Manufacturer Cell Sciences
Category
Type Proteins
Specific against Human
Format Lyophilized
Amount 20 ug
Host E.coli
Item no. CS-CRT700B
Targets CD267, TNF
eClass 6.1 34160400
eClass 9.0 42020190
Available
Biological Activity
Determined by its ability to block human BAFF induced T2B cell survival using a concentration range of 1.0-3.0 ?g/ml.
Description
TACI, a member of the TNF Receptor superfamily, is expressed in the small intestine, spleen, thymus, peripheral blood leukocytes, activated T cells, and resting B cells. TACI binds to both APRIL and BAFF and can stimulate the activation of transcription factors, NF-kappaB, AP-1, and mediates calcineurin dependent activation of NF-AT (nuclear-factor of activated T cell). TACI also plays a key role in the stimulation of B and T cell function. Soluble TACI inhibits APRIL-stimulated proliferation of primary B-cells by booking the binding of APRIL to the membrane anchored TACI receptor. Recombinant human TACI is soluble 160 amino acid polypeptide (17.8 kDa) comprising the TNFR homologous cysteine rich extracellular domain of the TACI protein.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 20 ug
Available: In stock
available

Delivery expected until 5/23/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close